Hypertension

Solera Health Expands its Curated Network to Help Payers and Employers Address High-Cost Cardiometabolic Disease

Retrieved on: 
Tuesday, April 16, 2024
Mortality, Genetics, International Journal of Obesity, Diabetes, Weight loss, Obesity, Solera, Patient, Movement, Hypertension, Cardiovascular disease, Longevity, Anxiety, Sleep, HALO, Disease, Pharmaceutical industry

The additional solutions enable payers and employers to address high-cost conditions associated with cardiometabolic health – integrating several proven, industry-leading digital health partners.

Key Points: 
  • The additional solutions enable payers and employers to address high-cost conditions associated with cardiometabolic health – integrating several proven, industry-leading digital health partners.
  • New solutions enhance Solera’s ability to impact hypertension, high cholesterol, diabetes prevention and weight management – and include Ciba Health, Digbi Health and Wondr Health.
  • Diabetes and cardiovascular disease are among the most expensive and prevalent diseases in the U.S., affecting over 121 million Americans.
  • "Cardiometabolic conditions remain a leading cause of preventable morbidity and mortality while accounting for over 30% of healthcare costs in the United States alone,” said Dr. Byron Crowe, Chief Medical Officer at Solera Health.

Digital Therapeutics Market Global and Regional Analysis and Forecast, 2023-2033: Utilization of AI and ML with Digital Therapeutics Growing in Prominence - ResearchAndMarkets.com

Retrieved on: 
Friday, April 12, 2024
General Health, Mental Health, Health, Physical Therapy, Telemedicine, Virtual Medicine, Digital therapeutics, Tradition, Investment, Risk, Country, Region, Software, Health care, Diabetes, Privacy, Digital, Therapy, Pain management, Patient, Data collection, Self-management, Hypertension, Rehabilitation, Security, Behavior, Algorithm, Growth, Global health

Multiple Benefits Provided by Digital Therapeutics over Traditional Treatment: The adoption of digital therapeutics is surging due to their personalized, technology-driven approach to managing various conditions.

Key Points: 
  • Multiple Benefits Provided by Digital Therapeutics over Traditional Treatment: The adoption of digital therapeutics is surging due to their personalized, technology-driven approach to managing various conditions.
  • Continuous Technological Advancements Driving the Adoption of Digital Therapeutics: Digital therapeutics is rising, fueled by technology and widespread smartphones.
  • Increasing Demand for Cost-Effective Solutions Creating a Demand for Digital Therapeutics: As healthcare costs are increasing, digital therapeutics rise as a cost-effective alternative.
  • Rising Fundings and Investment in Digital Therapeutics: The digital therapeutics market is experiencing an investment boom, propelling its growth and paving the way for healthcare advancements.

71 Remote Patient Monitoring Companies Earn Highest Certification for Healthcare Excellence from Smart Meter in 2023

Retrieved on: 
Thursday, April 11, 2024
Other Health, Mobile, Wireless, General Health, Telemedicine, Virtual Medicine, Biometrics, Medical Devices, Technology, 5G, Health Technology, Biotechnology, Health, Diabetes, Certification, HIPAA, CCM, RPM, Research, Smart meter, Vital signs, Patient, Physician, Hypertension, Howard University, Chronic care management

Smart Meter, the number one supplier of Cellular Remote Patient Monitoring (RPM)™, has confirmed that 71 out of 867 RPM healthcare distributors have earned the highest level of certification for delivering exceptional service to providers, patients, and healthcare systems in 2023.

Key Points: 
  • Smart Meter, the number one supplier of Cellular Remote Patient Monitoring (RPM)™, has confirmed that 71 out of 867 RPM healthcare distributors have earned the highest level of certification for delivering exceptional service to providers, patients, and healthcare systems in 2023.
  • These companies include RPM service providers and Chronic Care Management (CCM) platforms that have met or exceeded Smart Meter’s criteria for quality, reliability, and customer service.
  • RPM and CCM companies continue to grow in their importance in transforming healthcare delivery.
  • “Our RPM and CCM SmartPartners are the most innovative and knowledgeable organizations providing critical healthcare monitoring technology and services to care providers,” said Casey Pittock, CEO of Smart Meter.

OMRON Donates Some 3,200 Units of Blood Pressure Monitors to Global Blood Pressure Screening Campaign on World Hypertension Day

Retrieved on: 
Friday, April 26, 2024
Humidity, International Society, MMM, Stroke, Embolism, Atrial fibrillation, ZERO, Risk, Blood pressure, Research, Hypertension, ECG, OMRON, Incidence, Patient, Business, Cardiovascular disease, Death, Temperature, PLOS, Heart failure, Pharmaceutical industry

MMM was established by the International Society of Hypertension in 2017, and since then the Company has participated in this global campaign.

Key Points: 
  • MMM was established by the International Society of Hypertension in 2017, and since then the Company has participated in this global campaign.
  • May 17 is set to be the World Hypertension Day, and there are diverse events organized by regional societies and committees worldwide.
  • Blood pressure fluctuates throughout the day in response to a variety of factors such as temperature, humidity, and physical factors including stress.
  • Therefore, it is essential to monitor blood pressure at home in addition to regular health checkups at medical facilities.

OMRON Donates Some 3,200 Units of Blood Pressure Monitors to Global Blood Pressure Screening Campaign on World Hypertension Day

Retrieved on: 
Friday, April 26, 2024
Humidity, International Society, MMM, Stroke, Embolism, Atrial fibrillation, ZERO, Risk, Blood pressure, Research, Hypertension, ECG, OMRON, Incidence, Patient, Business, Cardiovascular disease, Death, Temperature, PLOS, Heart failure, Pharmaceutical industry

MMM was established by the International Society of Hypertension in 2017, and since then the Company has participated in this global campaign.

Key Points: 
  • MMM was established by the International Society of Hypertension in 2017, and since then the Company has participated in this global campaign.
  • May 17 is set to be the World Hypertension Day, and there are diverse events organized by regional societies and committees worldwide.
  • Blood pressure fluctuates throughout the day in response to a variety of factors such as temperature, humidity, and physical factors including stress.
  • Therefore, it is essential to monitor blood pressure at home in addition to regular health checkups at medical facilities.

DrFirst and PatchRx Partnership Combines Medication History with Daily Patient Adherence Data

Retrieved on: 
Tuesday, April 23, 2024
Prescription, Health, Death, Diabetes, Partnership, Patient, Timing, Hypertension, Pharmaceutical industry

ROCKVILLE, Md. and TULSA, Okla., April 23, 2024 /PRNewswire/ -- Health technology pioneer DrFirst and PatchRx, a medication adherence company, today announced a partnership to close the gap between a healthcare provider's recommended medication therapy and the patient's actual medicine-taking behavior.

Key Points: 
  • and TULSA, Okla., April 23, 2024 /PRNewswire/ -- Health technology pioneer DrFirst and PatchRx , a medication adherence company, today announced a partnership to close the gap between a healthcare provider's recommended medication therapy and the patient's actual medicine-taking behavior.
  • "There's a massive data gap in healthcare between when patients fill prescriptions and when patients actually take the medication, resulting in critical adherence oversights.
  • Combining DrFirst's prescription fill data with our daily adherence insight gives doctors a complete picture of how well a patient is following their prescribed medication regimen with unprecedented granularity," said Andrew Aertker, co-founder and CEO of PatchRx.
  • "Timing is everything when it comes to effective treatment of complex conditions," said G. Cameron Deemer, CEO of DrFirst.

Dr. Mauricio Gonzalez Selects Fastlane as Agency of Record

Retrieved on: 
Thursday, April 18, 2024
American Diabetes Association, Health, Heart, Diabetes, Exercise, AARP, Hypertension, Quality of life, Organization, American Heart Association

NEW YORK, April 18, 2024 /PRNewswire-PRWeb/ -- Dr. Mauricio Gonzalez, best known as Dr. Mau, an award-winning, triple board-certified physician in internal, emergency, and obesity medicine based in New York City, has selected Fastlane as the agency of record (AOR) for his rapidly-growing, health education business. Driven by a mutual goal of strengthening Dr. Mau's social reach and impact and further developing strategic partnerships, this alliance is poised to advance his brand profile within the healthcare and wellness industries.

Key Points: 
  • "I am genuinely excited to partner with Fastlane to amplify my mission and message and reach a broader audience.
  • A Fastlane specialty is identifying untapped opportunities within specific market segments and devising targeted strategies to produce positive business outcomes.
  • "Fastlane is honored to partner with such a high profile and well-respected healthcare practitioner and thought leader like Dr. Mau," said Chris Faust, Founder and CEO of Fastlane.
  • Fastlane and Dr. Mau's collaboration marks a significant step towards bridging the information gap and advancing communications in the healthcare industry.

Dario Signs Two Employers for Cardiometabolic Suite with Integrated GLP-1 Solution

Retrieved on: 
Thursday, April 18, 2024
Diabetes, Prediabetes, Hypertension

NEW YORK, April 18, 2024 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO) ("Dario" or the "Company"), a leader in the global digital health market, announced today two new contracts to provide integrated chronic condition management solutions for two employers beginning in the second quarter of 2024.

Key Points: 
  • The employers, a national supply chain company and a regional education organization, selected Dario's cardiometabolic suite to help improve outcomes for employees with cardiometabolic health conditions, including diabetes, pre-diabetes, hypertension and weight management needs, including support for individuals taking a GLP-1 medication.
  • Dario combines intelligent technologies with billions of data insights gathered from a decade of consumer engagement to deliver highly personalized experiences that keep members engaged over time for optimal results.
  • Employees enrolled in Dario's cardiometabolic solution who are taking a GLP-1 medication will also have access to a tailored experience to support long-term behavior change.
  • "The trend towards integrated solutions continues to grow as employers look to reduce point solutions in favor of a single integrated solution that has a better member experience and has a lower cost of ownership when compared to managing multiple point solutions.

Cardiovascular Centers of America Announces Cardiac Ablation Service Line at Advanced Heart and Vascular in Deltona, Florida

Retrieved on: 
Wednesday, April 17, 2024
Patient, Node, Education minister, Volusia County, Florida, Risk, Supraventricular tachycardia, ASC, AFIB, CCA, Obesity, SVT, Physician, Hypertension, Abdominal ultrasonography, Health, Atrioventricular node, Ageing, Atrial fibrillation, Prevalence, Pharmaceutical industry

DELTONA, Fla., April 17, 2024 /PRNewswire/ -- Cardiovascular Centers of America (CCA) proudly announces the launch of Florida's the first complete cardiac ablation service line in an Ambulatory Surgery Center (ASC) at Advanced Heart and Vascular Surgery Center (Advanced Cardiovascular).

Key Points: 
  • DELTONA, Fla., April 17, 2024 /PRNewswire/ -- Cardiovascular Centers of America (CCA) proudly announces the launch of Florida's the first complete cardiac ablation service line in an Ambulatory Surgery Center (ASC) at Advanced Heart and Vascular Surgery Center (Advanced Cardiovascular).
  • The team at Advanced Cardiovascular  successfully performed the inaugural AFIB ablation procedure within a Florida ASC setting in April 2024.
  • Cardiovascular Centers of America proudly announces the launch of Fla.'s first complete cardiac ablation service line.
  • In addition to the AFIB milestone, Advanced Cardiovascular is also one of the first ASCs in Florida to perform SVT and AV Node cardiac ablation procedures, providing another vital treatment option.

March of Dimes Awards Two Basil O'Connor Grants to Study Triggers of Labor Onset, Barriers to Postpartum Heart Health

Retrieved on: 
Tuesday, April 16, 2024
Mortality, Randomized controlled trial, Mayo Clinic, Boston Medical Center, Preterm birth, Boston University, Risk, Pregnancy, Woman, Blood, Health, Placenta, Doctor of Philosophy, Research, HDP, Infant, Obstetrics, Gynaecology, DNA, Therapy, Senior counsel, MPH, Immunology, Hypertension, Data collection, Pre-eclampsia, Disease, Assistant, RCT, Basil, Nursing

Dr. Enninga's work will focus on the role of cell free (cf) fetal DNA on labor and preterm birth, which occurs before 37 weeks of pregnancy.

Key Points: 
  • Dr. Enninga's work will focus on the role of cell free (cf) fetal DNA on labor and preterm birth, which occurs before 37 weeks of pregnancy.
  • The placenta releases cf fetal DNA into the maternal bloodstream during pregnancy.
  • Her Basil O'Connor work will set the foundation for a planned randomized controlled trial (RCT) of postpartum patient navigation set to take place in 2027.
  • Together, both are supporting our mission to reduce preventable maternal and infant mortality and morbidity."